Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ARDX — Ardelyx, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,430,395
+$573,593 QoQ
Shares Held
280,470
+96.1% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 250 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ARDX ranks #120 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ARDX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,430,395 280,470
2026-03-31 $856,802 143,039
2025-12-31 $1,856,347 318,413
2025-09-30 $1,108,815 201,237
2025-06-30 $691,306 176,354
2025-03-31 $816,758 166,346
2024-12-31 $824,665 162,656
2024-09-30 $2,229,891 323,642
2024-06-30 $6,551,662 884,165
2024-03-31 $851,026 116,579
2023-12-31 $658,867 106,269
2023-09-30 $1,164,165 285,335
2023-06-30 $1,581,481 466,514
2023-03-31 $1,372,008 286,432
2022-12-31 $81,871 28,727
2022-09-30 $41,622 34,977
2022-06-30 $22,605 38,315
2022-03-31 $62,987 58,867
2021-12-31 $102,950 93,591
2021-09-30 $148,140 112,229
2021-06-30 $26,613 3,511
2021-03-31 $59,347 8,965
2020-12-31 $552,874 85,452
2020-09-30 $821,776 156,529
2020-06-30 $1,070,529 154,701
2020-03-31 $238,878 42,019